E6201

Ligand id: 7836

Name: E6201

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 4
Rotatable bonds 2
Topological polar surface area 116.09
Molecular weight 389.18
XLogP 2.69
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
E6201 has been assessed in the completed clinical trial NCT01268527 (Phase 2), for the treatment of psoriasis vulgaris. As of October 2018 there is only one active E6201 clinical trial registered with ClinicalTrials.gov, NCT03332589 (Phase 1), which will evaluate efficacy in metastatic melanoma patients.